aspirin has been researched along with Nasopharyngeal Carcinoma in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
Excerpt | Relevance | Reference |
---|---|---|
"Regular aspirin use has been associated to decreased risk of several cancers, but evidence on nasopharyngeal carcinoma is scanty." | 3.81 | Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy. ( Bosetti, C; Di Maso, M; Garavello, W; La Vecchia, C; Libra, M; Montella, M; Polesel, J; Serraino, D, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chang, H | 1 |
Tao, YL | 1 |
Ye, WJ | 1 |
Xiao, WW | 1 |
Xia, YF | 1 |
Gao, YH | 1 |
Xiao, X | 1 |
Zhang, Z | 1 |
Chang, ET | 1 |
Liu, Z | 1 |
Liu, Q | 1 |
Cai, Y | 1 |
Chen, G | 1 |
Huang, QH | 1 |
Xie, SH | 1 |
Cao, SM | 1 |
Shao, JY | 1 |
Jia, WH | 1 |
Zheng, Y | 1 |
Liao, J | 1 |
Chen, Y | 1 |
Lin, L | 1 |
Ernberg, I | 1 |
Huang, G | 1 |
Zeng, Y | 1 |
Zeng, YX | 1 |
Adami, HO | 1 |
Ye, W | 1 |
Di Maso, M | 1 |
Bosetti, C | 1 |
La Vecchia, C | 1 |
Garavello, W | 1 |
Montella, M | 1 |
Libra, M | 1 |
Serraino, D | 1 |
Polesel, J | 1 |
3 other studies available for aspirin and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Regular aspirin intake and prognosis of TxN2-3M0 nasopharyngeal carcinoma: A cohort study based on propensity score matching.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Disease-Free Survival; Female; Humans; Male; Middle Aged; M | 2020 |
Medical History, Medication Use, and Risk of Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Aspirin; Case-Control Studies; China; Chronic Disease; Female; Humans; Logistic Models; | 2018 |
Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Case-Control Studies; Fema | 2015 |